Skip to main content
Home

Breadcrumb

  1. Home
  2. Healthcare and Life Science

Healthcare and Life Science

10 June 2024

I do not live with diabetes – should I be monitoring my glucose with CGM?

Nowadays, CGMs are being promoted by various biotech companies and social media influencers as tools for understanding and improving health. Unfortunately, I can see a rise in poorly evidenced health messages. In addition, there are many misleading ads risking people’s health. More in ...

7 June 2024

Nuclera awarded £1.14M Innovate UK funding for development of eProtein Discovery

£790k FASST grant, in collaboration with DeepMirror, and £350k Engineering Biology grant awarded for platform development. ...

6 June 2024

MediMab Biotherapeutics opens bespoke laboratory facilities, created by Kadans Science Partner, at Abingdon Science Park, UK

New CL2 wet lab purpose-built facilities delivered by Kadans Science Partner will support MediMab Biotherapeutics to identify first-in-class immuno-oncology drugs that can actively target a range of advanced and solid tumours Kadans has also completed on Barton House, a new research...

31 May 2024

Time from EMA approval to CT outcome for first indication vs. AMSR

This post launches a series of infographics focused on pricing and market access trends of rare disease treatments in France. Each post in this series zooms into a specific PMA trend by leveraging RADAR, CRA’s orphan drug data repository that includes all orphan drugs granted EMA approv...

29 May 2024

Impact of medicare price “negotiation” program on small and large molecule medicines

The Inflation Reduction Act (IRA) directs the U.S. federal government to set a “Maximum Fair Price” (MFP) for the medicines with the highest spending in Medicare. The MFP will be implemented for selected small molecule drugs as early as nine years after approval, and as early as 13 year...

5 June 2024

VALANX Biotech announces promising results in first in-vivo study of novel protein conjugate therapy

Study demonstrates pre-clinical efficacy of lead program VLX101 in treating autoimmune disease ...

4 June 2024

Sphere Fluidics launches Cyto-CellectPLUS to accelerate cell line development workflows

Next-generation assay provides a rapid and cost-effective solution to quantify IgG production in single cells ...

4 June 2024

Living with paediatric asthma

A number of different management techniques can help in controlling asthma in children. The aim of these management techniques is to enable the child to have a “normal life”, free of asthma symptoms. This includes enabling the child to sleep without any asthmatic related disruptions, to...

3 June 2024

Sable&Hawkes deliver campaign graphics and new product illustrations for global biotech

Sable&Hawkes have delivered product and marketing illustrations, icons and infographics for global biopharma and life sciences company Sartorius. ...

3 June 2024

SolasCure selected for Innovate UK Global Incubator Programme in Houston

Programme delivered in partnership with the Texas Medical Centre Programme will support Aurase Wound Gel for future entry into US market, advancing SolasCure’s mission to transform chronic wound care for millions of patients worldwide Cambridge, UK 03 June 2024: SOLASCURE Ltd (Sol...

Pagination

  • First page «
  • Previous page ‹‹
  • …
  • Page 151
  • Page 152
  • Current page 153
  • Page 154
  • Page 155
  • …
  • Next page ››
  • Last page »
Receive our newsletter

Cambridge Network Limited is a company registered in England under company No. 3400152

The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

Email: [email protected], Tel: 01223 746801

© 2026 Cambridge Network. All Rights Reserved.

Website by KISS